CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.31 +0.01 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Other Non-Current Assets (2023)

CollPlant Biotechnologies' (CLGN) quarterly Other Non-Current Assets came in at $83000.0 in Q2 2023.

CollPlant Biotechnologies (CLGN) Other Non-Current Assets (2023) Analysis & Trends

CollPlant Biotechnologies (CLGN) has 1 years of Other Non-Current Assets data on file, last reported at $83000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 618.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 109.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 65.13 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 202.31 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 62.96 Mn
10 CollPlant Biotechnologies 4.26 Mn 4.26 Mn -243,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2023 83,000.00